Heet Healthcare Private Limited
Chandkheda, Ahmedabad, Gujarat
GST No. 24AADCH2305P1ZN
TrustSEAL Verified
Call 0804897428259% Response Rate
SEND EMAIL
Product Details:
| Minimum Order Quantity | 1 Vial |
| Usage | Clinical, Commercial, Personal |
| Packaging Size | Per Box 1 vial |
| Brand | Celon Laboratories |
| Product Type | Finished Product |
| Dosage Form (If Applicable) | Injection |
Uses of Celofos Injection
Celofos 1000mg Injection is used in the treatment of blood cancer, breast cancer, non-small cell lung cancer and ovarian cancer
How Celofos Injection works
Celofos 1000mg injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication
Side effects of Celofos Injection
Nausea, Vomiting, Anemia, Hair loss, decreased white blood cell count, Infection, Blood in urine, CNS toxicity.
Warnings
1. Alcohol-Celofos 1000mg Injection may cause excessive drowsiness and calmness with alcohol
2. Pregnancy-Celofos 1000mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
3. Lactation-Celofos 1000mg Injection is usafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breast feeding is not advisable.
4. Driving-Celofos 1000mg Injection may cause side effects which could affect your ability to drive.
5. Kidney-Celofos 1000mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Celofos 1000mg Injection may be needed. Please consult your doctor.
6. Liver-Celofos 1000mg Injection should be used with caution in patients with liver disease. Dose adjustment of Celofos 1000mg Injection may be needed. Please consult your doctor.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Brand | Celon Laboratories Ltd |
| Usage | Clinical, Hospital, Commercial, Personal |
| Dose | As directed by physician |
| Packaging Size | Per Box 1 Vial |
| Packaging Type | Vial |
| Form of Medicine | Injection |
| Product Type | Finished Product |
Uses of Bleocel Injection
Bleocel 15IU Injection is used in the treatment of cervical cancer, cancer of mouth, nasopharynx and par nasal sinuses, larynx, esophagus and skin cancer
How to use Bleocel Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Bleocel Injection works
Bleocel 15IU injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
Side effects of Bleocel Injection
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Brand | Panacea Biotec Ltd |
| Usage | Personal, Commercial, Clinical, Hospital |
| Dose | As directed by physician |
| Packaging Size | Per Box 1 vial |
| Packaging Type | Vial |
| Form of Medicine | Injection |
| Product Type | Finished Product |
| Dosage Form (If Applicable) | Injection |
Use of Cabapan Injection
Cabapan 60mg Injection is used in the treatment of prostate cancer
How Cabapan Injection works
Cabapan 60mg injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication
Side effects of Cabapan Injection
Additional Information:
Product Details:
| Composition | Bevacizumab400 MG |
| Dose | 400MG |
| Packaging Size | PER BOX 1 VIAL |
| Packaging Type | VIAL |
| Form of Medicine | Injection |
| Brand | Biocon Ltd. |
| Usage | Hospital |
Manufacturer: Biocon Ltd.
Composition: Bevacizumab 400 MG
Uses of Krabeva Injection
Krabeva 400 mg Injection is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian cancer and cervical cancer.
How Krabeva Injection works
Krabeva 400 mg Injection is a anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.
Major & minor side effects for Krabeva 400 mg/16 ml Injection
Black or Tarry stools.
Bleeding gums.
Body aches or Pain.
Burning, numbness, tingling in the arms and feet.
Chest pain.
Chills.
Cloudy urine.
Decreased urine output.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Brand | Biochem Pharmaceutical |
| Usage | Clinical, Hospital, Personal, Commercial |
| Dose | As directed by physician |
| Packaging Size | Per Box 1 Vial |
| Product Type | Finished Product |
| Dosage Form (If Applicable) | Injection |
What is Bionase?
Bionase is a cancer medication that interferes with the growth and spread of cancer cells in the body. Bionase Erwinia chrysanthemi is used to treat acute lymphocytic lymphoma.
Uses of Bionase Injection
Bionase 5000IU Injection is used in the treatment of blood cancer (Acute lymphocytic leukemia)
How Bionase Injection works
Asparaginase belongs to class of medications called antineoplastic agents. Asparaginase is an enzyme that interferes with natural processes necessary for cancer cell growth, thereby killing or stopping the growth of cancer cells.
Side effects of Bionase Injection
Breathlessness, Rash, Vomiting, Angioedema (swelling of deeper layers of skin), Nausea, Fatigue, Increased liver enzymes, Edema, Diarrhoea, Decreased blood pressure, Flushing (sense of warmth in the face, ears, neck and trunk), Decreased albumin level in blood, Increased glucose level in blood, Urticaria.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Packaging Size | Vial |
| Packaging Type | Vial |
| Brand | Cipla |
| Dose/Strength | 1mg/1ml |
CYTOCRISTIN Injection
Each ml contains
Vincristine Sulphate IP …..............1 mg
Mannitol IP...............................100 mg
Preservatives
Methyl Paraben IP..................0.13% w/v
Propyl Paraben IP...................0.02% w/v
in water for injection IP......................q.s.
Indications
Vincristine sulphate is used either alone or in conjunction with other oncolytic drugs for the treatment of:
Dosage
Adults: Usually administered intravenously at weekly intervals; recommended dose is 1.4 to 1.5 mg/m2 up to a maximum weekly dose of 2 mg.
Children: The suggested dose is 1.4 to 2 mg/m2 given on a weekly basis with a maximum weekly dose of 2 mg. For children weighing 10 kg or less the starting dose should be 0.05 mg/kg administered as a weekly intravenous injection.
Administration
The concentration of Vincristine Sulphate Injection is 1 mg/mL. Do not add extra fluid to the vial prior to removal of the dose. Withdraw the solution of Vincristine Sulfate Injection, USP into an accurate dry syringe, measuring the dose carefully.
Contraindications
Side Effects
Alopecia, sensory loss, paresthesia, difficulty in walking, slapping gait, loss of deep-tendon reflexes, muscle wasting, generalized sensorimotor dysfunction
Storage
Store between 2°C and 8°C in refrigerator. Do not freeze. Protect from light.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Usage | Clinical, Commercial, Personal, Hospital |
| Dose | 440 mg |
| Product Type | Finished Product |
| Packaging Size | Vial |
USA FDA Approved.
Delivery to USA wthin 2 to 3 days.
Canmab Injection Details:-
WHAT DO YOU MEAN BY CANMAB 440MG INJECTION?
Canmab Trastuzumab is one of a group of cancer drugs called monoclonal antibodies. Monoclonal antibodies are sometimes called targeted therapies because they work by ‘targeting’ specific proteins (receptors) on the surface of cells. Some cancers have too much of a protein called human epidermal growth factor receptor 2 (HER2) on the surface of their cells. These are called HER2-positive cancers. The extra HER2 receptors stimulate the cancer cells to divide and grow. Trastuzumab locks on to the HER2 protein and blocks the receptor. This stops the cells from dividing and growing.
WHAT ARE THE USES OF TRASTUZUMAB 440 MG INJECTION?
Canmab is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is mainly used to treat certain types of breast cancer or stomach cancer.
WHAT ARE THE POSSIBLE SIDE-EFFECTS OF CANMAB TRASTUZUMAB 440MG INJECTION?
Some side effects may occur during the injection. Speak your doctor right away if you feel dizzy, nauseated, light-headed, weak, short of breath, or if you have a headache, fever, chills, sudden chest pain, wheezing, dry cough, hives, or swelling of your face, lips, tongue, or throat.
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 vial |
| Usage | Hospital |
Medicine composition: Cyclophosphamide
Manufactured by: Baxter
Uses of Endoxan 1000 mg Injection
· Malignant Disease · Ovarian Cancer · Breast cancer · Nephrotic SyndromeHow Endoxan Injection works
Endoxan 1000 mg Injection is an anti-cancer medication with immunosuppressive property. In cancer, it works by damaging the genetic material (DNA and RNA) of the cancer cells, thereby stopping their growth and multiplication.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Nausea and vomiting occur in most cases for a short period soon after injections, and should be treated with antiemetics.
Alopecia from slight to severe is frequently observed during cyclophosphamide treatment but hair grows again after a while.
Haemorrhagic cystitis may occur during high dosage cyclophosphamide treatment. Prophylactic high fluid intake and sodium bicarbonate instillations are recommended for relief of symptoms.
The leucotoxic effect described above is usually relatively mild; even severe leucopenias, when they do occur, tend to be quickly reversible.
Thrombocytopenias of below 100 000 are rare.
Haemopoiesis is practically never inhibited.
A teratogenic effect has been pharmacologically established.
Avoid skin contact. In case of accidental spillage, washing with large quantities of soap and water is recommended.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Medicine Type | Allopathic |
| 1 Box Contain (Bottle) | 1 Injection in 1 vial |
| Storage Type (Degree Celsius) | 2 to 8 degree Celsius |
Composition:
Ifosfamide (1gm)
Primarily used for:
Blood cancer, Breast cancer, and Non-small cell lung cancer
Side effects:
Nausea, Vomiting, Anemia, Hair loss, decreased white blood cell count, Infection, Blood in urine
How Holoxan Injection works:
Holoxan 1gm injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
Expert advice for Holoxan Injection:
· Women should use birth control method to prevent pregnancy while receiving ifosfamide and for 6 months after treatment and men should not father a child during therapy with ifosfamide.
· You should be regularly undergo kidney function test, urine tests, complete blood cell counts, and other blood tests to monitor progress or to check for side effects while using ifosfamide.
· Do not drive or operate heavy machinery as ifosfamide may make you feel sleepy or dizzy.
· Avoid consuming alcohol while taking ifosfamide as it may worsen the side effects.
· Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Storage:
It is stored in 2° C to 8° C temperature.
Additional Information:
Product Details:
| Minimum Order Quantity | 10 Box |
| Packaging Size | Vial |
| Packaging Type | Vial |
| Dose/Strength (ex. 1 mg or 1 ml) | 1 gm |
| Usage | Clinical, Hospital, Personal |
| Brand | GETWELL |
| Dose | 1000 mg |
Name of the medicinal product
Gemcitabine 1000 mg, powder for solution for infusion
Qualitative and quantitative composition
Each vial contains 1000 mg gemcitabine (as hydrochloride)
Excipients with known effect:
Each vial contains 17.5 mg sodium.
One ml of the reconstituted solution for infusion contains 38 mg gemcitabine (as hydrochloride).
Pharmaceutical form
Powder for solution infusion.
White to off-white lyophilized cake.
Clinical particulars
Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin.
Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.
Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine monotherapy can be considered in elderly patients or those with performance status 2.
Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy.
Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Packaging Size | Vial |
| Brand | Darzalex |
| Composition | Daratumumab 400 |
| Manufacturer | janssen |
| Treatment | Cancer |
| Prescription/Non prescription | Prescription |
| Form | Injection |
Generic Name: daratumumab
Manufactured by: Janssen
Packaging Size: Vial
Packaging Type: Injection
Dose/Strength (400 MG)
What is Darzalex?
Darzalex (daratumumab) is a monoclonal antibody that blocks a certain protein in the body that can affect tumor cell growth. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.
Darzalex is used to treat multiple myeloma (bone marrow cancer). It is usually given after other cancer medicines have been tried without success.
Darzalex is used alone when given to a person who has been treated with at least 3 prior cancer medicines.
For a person treated with only one prior cancer medicine, Darzalex may be given in combination with another cancer medicine (either lenalidomide or bortezomib) plus a steroid medicine called dexamethasone.
Dosage:
Newly diagnosed multiple myeloma
Combination therapy with bortezomib, melphalan and prednisone Indicated in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT) Weeks 1-6: 16 mg/kg IV infusion once weekly (total of 6 doses) Weeks 7-54: 16 mg/kg IV infusion every 3 weeks (total of 16 doses)
Week 55 onwards until disease progression: 16 mg/kg IV infusion every 4 weeks
Weeks 7-54: 16 mg/kg IV infusion every 3 weeks (total of 16 doses)
Week 55 onwards until disease progression: 16 mg/kg IV infusion every 4 weeks
Common Darzalex side effects may include:
Nausea, diarrhea;
Shortness of breath;
Nerve problems;
Swelling in your hands or feet;
Fever, feeling tired;
Muscle spasms, back pain; or
Cold symptoms such as stuffy nose, sneezing, cough, sore throat.
Storage and Stability
Store in a refrigerator at 2°C to 8°C (36°F to 46°F).
Do not freeze or shake. Protect from light. This product contains no preservativeAdditional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Product Type | Finished Product |
| Dosage Form (If Applicable) | Injection |
Additional Information:
Product Details:
| Dose/Strength | DARZALEX 100 MG |
| Form of Medicine | Injection |
Generic Name: daratumumab
Manufactured by: Janssen
Dosage Forms & Strengths: 100mg/5mL (20mg/mL)
What is Darzalex?
Darzalex (daratumumab) is a monoclonal antibody that blocks a certain protein in the body that can affect tumor cell growth. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.
Darzalex is used to treat multiple myeloma (bone marrow cancer). It is usually given after other cancer medicines have been tried without success.
Darzalex is used alone when given to a person who has been treated with at least 3 prior cancer medicines.
For a person treated with only one prior cancer medicine, Darzalex may be given in combination with another cancer medicine (either lenalidomide or bortezomib) plus a steroid medicine called dexamethasone.
Darzalex dosing information
The recommended dose of daratumumab is 16 mg/kg actual body weight according to the following schedule.
Monotherapy and in combination with lenalidomide or pomalidomide and low-dose dexamethasone:
Weeks 1 to 8 - weekly (total of 8 doses)
Weeks 9 to 24 - every two weeks (total of 8 doses)
Week 25 onwards until disease progression - every four weeks
In combination with bortezomib and dexamethasone:
Weeks 1 to 9 - weekly (total of 9 doses)
Weeks 10 to 24 - every three weeks (total of 5 doses)
Week 25 onwards until disease progression - every four weeks
Common Darzalex side effects may include:
Nausea, diarrhea;
Shortness of breath;
Nerve problems;
Swelling in your hands or feet;
Fever, feeling tired;
Muscle spasms, back pain; or
Cold symptoms such as stuffy nose, sneezing, cough, sore throat.
Storage and Stability
Store in a refrigerator at 2°C to 8°C (36°F to 46°F).
Do not freeze or shake. Protect from light. This product contains no preservativeAdditional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Dose | As Directed by Physician |
| Usage | Personal, Hospital, Commercial, Clinical |
| Packaging Size | 1 Vial per box |
| Packaging Type | Vial |
| Form of Medicine | Injection |
COMPOSITION
Each 20 ml vial of MyMust contains 100 mg of Bendamustine as lyophilized powder.
INDICATION
MyMust (Bendamustine Hydrochloride) Injection is indicated for the treatment of patients with indolent B-cell Non-Hodgkin’s lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab containing regimen. MyMust (Bendamustine hydrochloride) is also indicated for the treatment of patients with Chronic Lymphocytic Leukaemia (CLL). Efficacy relative to rst line therapies other than chlorambucil has not been established
Stability
The diluted solution of Bendamustine is stable at controlled room temperature (15-25°C) for 3 hours and for 24 hours when it is stored at 2-8°C. Safe Handling and Disposal As with any other cytotoxic agent, appropriate care should be taken during preparation, administration and disposal of Bendamustine. Adverse Events associated with the use of Bendamustine in CLL may include, but are not limited to, the following: Neutropenia, Diarrhea, Thrombocytopenia, Fatigue, Anemia, Asthenia, Leukopenia, Pyrexia Lymphopenia Infections, Nausea, Hyperuricemia, Vomiting, Skin Rash
Packaging
MyMust 100 mg for injection is supplied in 20 ml amber colour vials containing 100 mg of lyophilized, white to off-white powder of Bendamustine hydrochloride and a 20ml sterile water for injection IP, housed in a carton.
STORAGE
MyMust should be stored below 25°C, with excursions permitted up to 30°C. Retain the product in the original carton until the time of use to protect it from light
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Usage | Hospital, Commercial, Clinical, Personal |
| Dose | 200mg per vial |
| Packaging Size | Vial |
| Packaging Type | Vial |
Uses of Celdaz Injection
Celdaz 200mg Injection is used in the treatment of malignant melanoma and Hodgkin’s disease.
Side effects of Celdaz Injection
Nausea, Vomiting, Anemia, Decreased white blood cell count, Loss of appetite.
How Celdaz Injection works
Celdaz 200mg injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
Expert advice for Celdaz Injection
· Dacarbazine injection must be given under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer.
· You should not eat anything for 4 to 6 hours before taking dacarbazine injection. This may help prevent severe nausea or vomiting.
· Dacarbazine may make your skin sensitive to sunlight. Avoid any unnecessary or prolonged exposure to sunlight and wear protective clothing, sunglasses, and sunscreen.
· Dacarbazine can cause a severe decrease in the number of blood cells in your bone marrow increasing the risk of developing serious infection or bleeding. Consult your doctor immediately if you experience symptoms, such as, fever, sore throat, ongoing cough and congestion, or other signs of infection; unusual bleeding or bruising.
· Dacarbazine may cause serious or life-threatening liver damage. Consult your doctor immediately if you experience symptoms, such as nausea, extreme tiredness, unusual bleeding or bruising, lack of energy, loss of appetite, pain in the upper right part of the stomach, or yellowing of the skin or eyes.
· It is advisable for men undergoing dacarbazine treatment to take contraceptive measures during and for 6 months after termination of therapy.
· Do not drink alcohol while on dacarbazine treatment.
· Do not drive or operate machines while using dacarbazine.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Usage | Clinical, Hospital, Personal, Commercial |
| Packaging Size | 1 Vial Per Box |
| Packaging Type | Vial |
Bendamustine, an anti-cancer drug, is prescribed for the treatment of chronic lymphocytic leukemia. The drug is also prescribed for the treatment of indolent B-cell non-Hodgkin’s lymphoma that is drug-resistant to other therapies.
Precautions
Bendamustine is contraindicated in smokers, patients with hepatic diseases, metabolic disorders, infections, immune disorders, liver diseases and renal disorders. Bendamustine may impair thinking and mental alertness. Do not use drive vehicles or operate machineries while taking Bendamustine.
Other Drug Interactions
Bendamustine may interact with
· thiabendazole,
· ciprofloxacin,
· carbamazepine
· fluvoxamine,
· cimetidine
· Omeprazole.
Dosage
Chronic Lymphocytic Leukemia (Adults):
The recommended adult dosage of Bendamustine for treatment of chronic lymphocytic leukemia is 100 mg/m2, IV, on days 1 & 2 of 28 days cycle.
The treatment can be continued up to 6 cycles. The infusion should be administered over 30 minutes.
Dosage modifications may be needed in case of hematological toxicity. In such cases 50 mg/m2 on days 1&2 of each cycle. In severe toxicity, the dosage can be reduced to 25 mg/m2 on days 1 and 2 of each cycle. In case of severe non-hematological toxicity, 50 mg/m2 on days 1 & 2 of each cycle should be administered.
Non-Hodgkin''s Lymphoma (Adults):
The recommended adult dosage of Bendamustine for treatment of chronic lymphocytic leukemia is 120 mg/m2, IV, on days 1 & 2 of 21 days cycle. The treatment can be continued up to 8 cycles. The infusion should be administered over 60 minutes.
Dosage modifications may be needed in case of hematological toxicity. In such cases 90 mg/m2 on days 1 & 2 of each cycle. In severe toxicity, the dosage can be reduced to 60 mg/m2 on days 1 and 2 of each cycle. In case of severe non-hematological toxicity, 60-90 mg/m2 on days 1 & 2 of each cycle should be administered.
Bendamustine and Pregnancy
Contraindicated in pregnancy
USFDA pregnancy category D. Bendamustine can harm the unborn fetus. Perform pregnancy tests before using Bendamustine. Use effective contraceptive modes to prevent unintended pregnancies while taking Bendamustine.
Bendamustine and Lactation
It is unclear whether the drug could pass through the breast milk to a breast feeding baby. Consult your physician before taking Bendamustine, if you are nursing mother.
Storage
Store at 20-25°C.
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Usage | Commercial, Hospital, Clinical, Personal |
| Dose | As directed by physician |
| Packaging Size | Per Box 1 Vial |
| Form of Medicine | Injection |
| Product Type | Finished Product |
| Dosage Form (If Applicable) | Injection |
Additional Information:
Product Details:
| Minimum Order Quantity | 1 Vial |
| Usage | Clinical, Personal, Commercial, Hospital |
| Dose | 10mg/10ml |
| Packaging Size | Vial |
| Packaging Type | Vial |
| Form of Medicine | Injection |
| Certification | ISO |
| Brand | Cipla |
What is Cytoblastin?
Cytoblastin (Vinblastine Sulphate) Intravenous Injection is indicated in the treatment of several different forms of cancer including Hodgkin''s disease, lymphocytic lymphoma, histiocytic lymphoma, mycosis fungoides, and carcinoma of the testes, Kaposi''s sarcoma and Letterer-Siwe disease (histiocytosis X). Vinblastine Sulphate is what is know as a vinca alkaloid. Its mechanism of action is the inhibition of microtubule formation in the mitotic spindle within cancer cells. This results in the slowing of their replication and the spread of the cancer.
How is Cytoblastin used?
Cytoblastin can only be administered by intravenous injection. If Vinblastine is administered via any other route it can become fatal.
Your individualized dosage will be prescribed by your doctor and is dependent on the type of cancer being treated and a variety of personal factors. A starting dosage 3.7mg/m2 of body surface area is often prescribed for adults, but this is a guideline only. Follow the exact instructions provided by your doctor. Do not exceed a maximum dose of 18.5 mg/m2 body surface area.
Adverse effects
Cytoblastin (Vinblastine) can result in some unwanted side effects including:
Tell your doctor if you experience any of the above while taking Cytoblastin (Vinblastine Sulphate).
Warnings
Cytoblastin must be given only by intravenous administration. Taking Vinblastine by any other route can result in fatality.
Do not use when significant granulocytopenia is present, unless this is caused by the disease being treated.
Do not use in cases of bacterial infections. The infections must be brought under control prior to the initiation of therapy with vinblastine sulfate.Additional Information:
Additional Information:
Additional Information:
Additional Information: